A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity

Nature Genetics
R E StraubD Walsh

Abstract

In 265 Irish pedigrees, with linkage analysis we find evidence for a vulnerability locus for schizophrenia in region 6p24-22. The greatest lod score, assuming locus heterogeneity, is 3.51 (P = 0.0002) with D6S296. Another test, the C test, also supported linkage, the strongest results being obtained with D6S296 (P = 0.00001), D6S274 (P = 0.004) and D6S285 (P = 0.006). Non-parametric analysis yielded suggestive, but substantially weaker, findings. This locus appears to influence the vulnerability to schizophrenia in roughly 15 to 30% of our pedigrees. Evidence for linkage was maximal using an intermediate phenotypic definition and declined when this definition was narrowed or was broadened to include other psychiatric disorders.

References

Jan 1, 1992·Human Heredity·N Risch, L Giuffra
Jun 1, 1992·Annals of Medicine·M C O'Donovan, M J Owen
Jan 1, 1992·Genetic Epidemiology·V J VielandD A Greenberg
Aug 11, 1992·Archives of General Psychiatry·J B WilliamsB Rounsaville
Jan 1, 1992·Genetic Epidemiology·W J ChenM T Tsuang
Jan 1, 1990·Genetic Epidemiology·F Clerget-DarpouxC Bonaïti-Pellié
Aug 16, 1990·Nature·M Baron
Jan 1, 1989·Schizophrenia Bulletin·K S KendlerD Walsh
Jan 1, 1988·Genetic Epidemiology·K LangeM Boehnke
Jan 1, 1987·Psychiatry Research·L R GoldinE S Gershon
Oct 23, 1987·Cell·H Donis-KellerE S Lander
Nov 1, 1995·Nature Genetics·B J MowryL Sharpe
Nov 1, 1995·Nature Genetics·H GurlingJ Brynjolfsson
Nov 1, 1995·Nature Genetics·S E AntonarakisB Dombroski
Aug 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·K S Kendler, D Walsh
Jun 15, 1994·American Journal of Medical Genetics·C R Cloninger
Sep 30, 1994·Science·E S Lander, N J Schork
Jan 1, 1993·Genomics·R E StraubT C Gilliam
Oct 1, 1993·Archives of General Psychiatry·K S KendlerD Walsh
Jan 1, 1994·The American Journal of Psychiatry·K S KendlerD Walsh
Dec 31, 1993·Cell·UNKNOWN European Chromosome 16 Tuberous Sclerosis Consortium
Jan 1, 1993·Schizophrenia Bulletin·K S Kendler, S R Diehl
May 1, 1993·American Journal of Medical Genetics·P WrightR M Murray

❮ Previous
Next ❯

Citations

Jan 1, 1997·Social Psychiatry and Psychiatric Epidemiology·K S Kendler
Jan 1, 1996·European Archives of Psychiatry and Clinical Neuroscience·V AroltE Schwinger
Jan 1, 1996·European Archives of Psychiatry and Clinical Neuroscience·E JönssonG Sedvall
Apr 3, 2002·Journal of Biosciences·Suman PrasadB K Thelma
Jan 1, 1996·Journal of Molecular Neuroscience : MN·K C MurphyP McGuffin
Jun 9, 2004·Neurotoxicity Research·Brien Riley
Mar 28, 2002·Cellular and Molecular Life Sciences : CMLS·D M WaterwortL M Brzustowicz
Dec 21, 2000·Current Psychiatry Reports·C N PatoM T Pato
Dec 21, 2000·Current Psychiatry Reports·M T TsuangS V Faraone
Apr 27, 2011·Molecular Neurobiology·Ariana P MullinVictor Faundez
Oct 16, 2003·Current Opinion in Pharmacology·Michael Williams
Sep 18, 2004·Schizophrenia Research·Hsiao-Mei Liao, Chia-Hsiang Chen
Sep 22, 2001·Biological Psychiatry·G WintererD R Weinberger
Oct 26, 2002·Biological Psychiatry·Marsha A WilcoxMing T Tsuang
Jun 6, 2003·Neuroscience and Biobehavioral Reviews·Albert Hung Choy Wong, Hubert H M Van Tol
Mar 17, 2000·Brain Research. Brain Research Reviews·L E DeLisi
Jul 10, 1998·Psychiatry Research·L K JacobsenJ L Rapoport
Jul 24, 2002·Neuroscience Research·Chieko KatoTsukasa Sasaki
Feb 13, 2001·Schizophrenia Research·P WrightR M Murray
Nov 14, 2001·Schizophrenia Research·D L GarverB Barnes
Mar 22, 2003·Schizophrenia Research·Tae-Youn JunAlessandro Serretti
Feb 19, 1998·Schizophrenia Research·L E DeLisi
Mar 9, 2000·Schizophrenia Research·T MiyaokaS Dekio
Feb 7, 1998·Current Opinion in Neurobiology·M F Egan, D R Weinberger
Mar 1, 1997·Molecular Medicine Today·G Kirov, R Murray
Oct 8, 2008·Development and Psychopathology·Katherine H KarlsgodtTyrone D Cannon
Mar 10, 2000·Epidemiologia e psichiatria sociale·P Dazzan, R M Murray
Apr 1, 1996·Nature Genetics·J S WitteN J Schork
Apr 1, 1996·Nature Genetics·D Curtis
Nov 5, 1997·Nature Genetics·S O Moldin
Nov 1, 1995·Nature Genetics·H GurlingJ Brynjolfsson
Nov 1, 1995·Nature Genetics·S E AntonarakisB Dombroski
May 25, 2006·European Journal of Human Genetics : EJHG·Brien Riley, Kenneth S Kendler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.